دورية أكاديمية

Accuracy of and preferences for blood-based versus oral-fluid-based HIV self-testing in Malawi: a cross-sectional study.

التفاصيل البيبلوغرافية
العنوان: Accuracy of and preferences for blood-based versus oral-fluid-based HIV self-testing in Malawi: a cross-sectional study.
المؤلفون: O'Reilly A; Malawi Liverpool Wellcome Trust, Blantyre, Malawi. ailva.oreilly@nhs.net., Mavhu W; Centre for Sexual Health and HIV/AIDS Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe.; Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK., Neuman M; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Kumwenda MK; Malawi Liverpool Wellcome Trust, Blantyre, Malawi.; Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK., Johnson CC; Global HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland., Sinjani G; Malawi Liverpool Wellcome Trust, Blantyre, Malawi., Indravudh P; Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK., Choko A; Malawi Liverpool Wellcome Trust, Blantyre, Malawi.; Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK., Hatzold K; Population Services International, Cape Town, South Africa., Corbett EL; Malawi Liverpool Wellcome Trust, Blantyre, Malawi.; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
المصدر: BMC infectious diseases [BMC Infect Dis] 2024 Apr 02; Vol. 22 (Suppl 1), pp. 979. Date of Electronic Publication: 2024 Apr 02.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2001-
مواضيع طبية MeSH: Self-Testing* , HIV Infections*/diagnosis, Humans ; Male ; Female ; HIV ; Cross-Sectional Studies ; Malawi ; Self Care ; HIV Testing ; Surveys and Questionnaires ; Mass Screening/methods
مستخلص: Background: HIV self-testing (HIVST) can use either oral-fluid or blood-based tests. Studies have shown strong preferences for self-testing compared to facility-based services. Despite availability of low-cost blood-based HIVST options, to date, HIVST implementation in sub-Saharan Africa has largely been oral-fluid-based. We investigated whether users preferred blood-based (i.e. using blood sample derived from a finger prick) or oral fluid-based HIVST in rural and urban Malawi.
Methods: At clinics providing HIV testing services (n = 2 urban; n = 2 rural), participants completed a semi-structured questionnaire capturing sociodemographic data before choosing to test using oral-fluid-based HVST, blood-based HIVST or provider-delivered testing. They also completed a self-administered questionnaire afterwards, followed by a confirmatory test using the national algorithm then appropriate referral. We used simple and multivariable logistic regression to identify factors associated with preference for oral-fluid or blood-based HIVST.
Results: July to October 2018, N = 691 participants enrolled in this study. Given the choice, 98.4% (680/691) selected HIVST over provider-delivered testing. Of 680 opting for HIVST, 416 (61.2%) chose oral-fluid-based HIVST, 264 (38.8%) chose blood-based HIVST and 99.1% (674/680) reported their results appropriately. Self-testers who opted for blood-based HIVST were more likely to be male (50.3% men vs. 29.6% women, p < 0.001), attending an urban facility (43% urban vs. 34.6% rural, p = 0.025) and regular salary-earners (49.5% regular vs. 36.8% non-regular, p = 0.012). After adjustment, only sex was found to be associated with choice of self-test (adjusted OR 0.43 (95%CI: 0.3-0.61); p-value < 0.001). Among 264 reporting blood-based HIVST results, 11 (4.2%) were HIV-positive. Blood-based HIVST had sensitivity of 100% (95% CI: 71.5-100%) and specificity of 99.6% (95% CI: 97.6-100%), with 20 (7.6%) invalid results. Among 416 reporting oral-fluid-based HIVST results 18 (4.3%) were HIV-positive. Oral-fluid-based HIVST had sensitivity of 88.9% (95% CI: 65.3-98.6%) and specificity of 98.7% (95% CI: 97.1-99.6%), with no invalid results.
Conclusions: Offering both blood-based and oral-fluid-based HIVST resulted in high uptake when compared directly with provider-delivered testing. Both types of self-testing achieved high accuracy among users provided with a pre-test demonstration beforehand. Policymakers and donors need to adequately plan and budget for the sensitisation and support needed to optimise the introduction of new quality-assured blood-based HIVST products.
(© 2024. The Author(s).)
References: AIDS Behav. 2016 Apr;20(4):870-9. (PMID: 26438487)
BMC Infect Dis. 2023 Oct 17;22(Suppl 1):973. (PMID: 37848810)
Curr HIV/AIDS Rep. 2020 Aug;17(4):281-289. (PMID: 32519185)
PLoS One. 2020 Oct 5;15(10):e0239607. (PMID: 33017442)
PLoS One. 2014 Jul 22;9(7):e102812. (PMID: 25051160)
PLOS Glob Public Health. 2023 Feb 1;3(2):e0001438. (PMID: 36962976)
PLoS Med. 2015 Sep 08;12(9):e1001873. (PMID: 26348035)
Lancet Glob Health. 2021 Dec;9(12):e1632-e1633. (PMID: 34735863)
Curr HIV/AIDS Rep. 2022 Oct;19(5):394-408. (PMID: 35904695)
J Int AIDS Soc. 2019 Mar;22 Suppl 1:e25244. (PMID: 30907505)
PLoS Med. 2019 Jan 2;16(1):e1002719. (PMID: 30601823)
PLoS One. 2018 Sep 13;13(9):e0202491. (PMID: 30212525)
PLoS One. 2021 Apr 9;16(4):e0249701. (PMID: 33836036)
Lancet HIV. 2018 Jun;5(6):e277-e290. (PMID: 29703707)
J Clin Microbiol. 2003 May;41(5):2153-5. (PMID: 12734265)
Int J STD AIDS. 2016 Jun;27(7):531-6. (PMID: 25971262)
BMC Infect Dis. 2022 May 25;22(Suppl 1):494. (PMID: 35614397)
PLoS One. 2014 May 06;9(5):e85051. (PMID: 24802746)
Front Public Health. 2022 Nov 09;10:911932. (PMID: 36438254)
Curr Opin Infect Dis. 2018 Feb;31(1):14-24. (PMID: 29232277)
EClinicalMedicine. 2021 Jul 07;38:100991. (PMID: 34278282)
BMJ Glob Health. 2021 Jul;6(Suppl 4):. (PMID: 34275867)
Clin Infect Dis. 2021 Aug 16;73(4):e1018-e1028. (PMID: 34398952)
Bull World Health Organ. 2019 Nov 01;97(11):764-776. (PMID: 31673192)
PLoS Med. 2011 Oct;8(10):e1001102. (PMID: 21990966)
Lancet Glob Health. 2020 Jun;8(6):e744-e745. (PMID: 32446337)
AIDS Care. 2020 May;32(sup2):206-213. (PMID: 32164420)
J Int AIDS Soc. 2019 Mar;22 Suppl 1:e25245. (PMID: 30907515)
J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):449-53. (PMID: 17554213)
AIDS Behav. 2016 Apr;20(4):928-38. (PMID: 26511864)
Lancet HIV. 2019 Feb;6(2):e68-e69. (PMID: 30584046)
J Int AIDS Soc. 2019 Mar;22 Suppl 1:e25249. (PMID: 30907517)
AIDS Behav. 2014 Dec;18(12):2477-84. (PMID: 24691923)
معلومات مُعتمدة: 001 International WHO_ World Health Organization; Unitaid Unitaid
فهرسة مساهمة: Keywords: Cross-sectional study; HIV; Malawi; Men; Self-testing; Sub-Saharan Africa
تواريخ الأحداث: Date Created: 20240402 Date Completed: 20240404 Latest Revision: 20240518
رمز التحديث: 20240518
مُعرف محوري في PubMed: PMC10985843
DOI: 10.1186/s12879-024-09231-1
PMID: 38566003
قاعدة البيانات: MEDLINE
الوصف
تدمد:1471-2334
DOI:10.1186/s12879-024-09231-1